Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Somatoform Disorders × Breast × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 271 Pain, Postoperative 14 Neoplasm Metastasis 12 Neoplasms 9 Prostatic Neoplasms 8 Ovarian Neoplasms 7 Triple Negative Breast Neoplasms 6 Pain 6 Osteoporosis 6 Seroma 5 Colorectal Neoplasms 5 Cardiotoxicity 5 Breast Diseases 4 Breast Cancer Female 4 Neutropenia 3 Melanoma 3 Mastodynia 3 Lymphedema 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Brain Neoplasms 3 Bone Diseases, Metabolic 3 Vomiting 2 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sleep Initiation and Maintenance Disorders 2 Skin Diseases 2 Obesity 2 Neurotoxicity Syndromes 2 Multiple Myeloma 2

Interventions

dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03348696 2020-01-09

REaCT-TAPS

Ottawa Hospital Research Institute

Phase 4 Completed

Breast Neoplasms, Somatoform Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡